CXR (TSX) |

CXRX (NASDAQ) |

Navigation
  • About Us
    • Overview
    • Management
    • Board of Directors
    • Corporate Governance
    • Charters & Policies
    • Articles & Bylaws
  • Our Products
  • Our Companies
  • Investors
    • Overview
    • Events
    • Stock Information
    • Financials
    • Analyst Coverage
    • FAQs
  • News
  • Careers
  • Contact Us
  • Search
  • About Us
    • Overview
    • Management
    • Board of Directors
    • Corporate Governance
    • Charters & Policies
    • Articles & Bylaws
  • Our Products
  • Our Companies
  • Investors
    • Overview
    • Events
    • Stock Information
    • Financials
    • Analyst Coverage
    • FAQs
  • News
  • Careers
  • Contact Us
  • Search

Articles and Bylaws

 

Articles of Amalgamation

Concordia By-law No. 1

Concordia By-law No. 2

Certificate & Articles of Incorporation

Contact Us

Concordia International Corp.
277 Lakeshore Road East, Suite 302 Oakville, Ontario L6J1H9
Medical Information
1 877 370 1142

Product Information
productinfo@concordiarx.com

Compliance hotline
1 855 562 5982​

Investor Relations
investorrelations@concordiarx.com

 

Customer Contact Outside North America
Capital House, 85 King William Street
London, EC4N 7BL
United Kingdom
(T) +44 (0) 208 588 9100
(F) +44 (0) 208 588 9200
enquiries@concordiarx.com

 

Medical Information, Drug Safety and
Product Complaints

Email
medicalinformation@concordiarx.com
drugsafety@concordiarx.com
complaints@concordiarx.com

Phone
UK: +44 (0) 8700 70 30 33 or
+44 (0) 208 588 9131
Ireland: + 353 1890 25 24 73

Compliance Hotline
For call details or to make an email report please click: www.concordiarx.ethicspoint.com

 

Sign Up for Concordia Press Releases

  • Privacy Statement
  • Terms of Use
  • Site Map
© 2017 Copyright Concordia International Corp. All rights reserved. Created by NATIONAL Equicom